DJO Reports $233.6M in Net Sales for 3Q

DJO, a medical device company focusing on musculoskeletal, vascular and pain management health, reported a net sales of $233.6 million during the third quarter of 2010, a decrease from the $236.2 million reported for the third quarter of 2009, according to a company news release.

Advertisement

The company’s earnings could be contributed to an unfavorable change in foreign currency exchange rates and by the sales of non-core product lines in the prior year. The company experienced a net loss of $7.7 million, a decrease from last year’s third quarter loss of $11.4 million. The net loss is attributable to non-recurring integration charges and ongoing restructuring and acquisitions.

The company reported $78.16 in bracing and support net sales and $14,559 in surgical implant sales. International sales were reported as $54, 960, a decrease from last year’s report of $58,588.

Read the release on DJO’s 3Q FY 2010 financial report.

Read other coverage on 3Q FY 2010 financial reports:

– MAKO Surgical Corp. Reports $12M in 3Q Revenue, Up 79%

– ArthroCare Total Revenue Increases by 10.6% to $87.9M

– Integra LifeSciences Total Revenues Up 8.3% to $186.6M

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.